Company Name: bluebird bio, Inc.

bluebird bio, Inc. is a clinical-stage biotechnology company. The company is engaged in developing gene therapies for severe genetic and rare diseases. The company’s pipeline includes treatment candidates for childhood cerebral adrenoleukodystrophy (CCALD), beta-thalassemia major and severe sickle cell disease. The company also develops T cell-based cancer immunotherapies.

Ticker Symbol: BLUE (NASDAQ)

Company Website: www.bluebirdbio.com

Social Media:

Bluebird Bio Instagram

Bluebird Bio LinkedIn

Bluebird Bio Twitter

Bluebird Bio YouTube

Headquarters: Cambridge, Massachusetts